AZD-1678

• Description:

  AZD-1678 is a potent CCR4 receptor antagonist, with a pIC50 of 8.6[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H373

• Target:

  CCR

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/azd-1678.html

• Purity:

  98.12

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=S(C1=CC=CC(Cl)=C1Cl)(NC2=NC=C(F)N=C2OC)=O

• Molecular Formula:

  C11H8Cl2FN3O3S

• Molecular Weight:

  352.17

• Precautions:

  H302, H373

• References & Citations:

  [1]Nicholas Kindon, et al. Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS Med Chem Lett. 2017 Sep 1;8 (9) :981-986.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CCR4

• CAS Number:

  942137-41-9